Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

98.99
-1.6200-1.61%
Volume:190.68K
Turnover:19.00M
Market Cap:6.43B
PE:-7.03
High:103.12
Open:102.78
Low:98.25
Close:100.61
52wk High:130.00
52wk Low:63.23
Shares:64.93M
Float Shares:56.42M
Volume Ratio:0.57
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.0800
EPS(LYR):-0.4700
ROE:-702.97%
ROA:-6.79%
PB:-616.74
PE(LYR):-210.62

Loading ...

Stock Track | Mirum Pharmaceuticals (MIRM) Plunges 18% in 24 Hours as Q2 Loss Widens Significantly, Misses Estimates

Stock Track
·
Aug 06

Earnings Flash (MIRM) Mirum Pharmaceuticals Posts Q2 Loss -$1.06 per Share

MT Newswires Live
·
Aug 06

Mirum Pharmaceuticals, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Stock Track | Mirum Pharmaceuticals Plunges 14.18% After-Hours as Q2 Loss Widens, Misses Estimates

Stock Track
·
Aug 06

Mirum SVP, Global Controller Jolanda Howe Sells 1,840 Shares for $193,733.6

Reuters
·
Aug 06

Mirum Pharmaceuticals Q2 Sales Rise, Lifts Outlook

Reuters
·
Aug 06

Mirum Q2 FY26 Operating Loss Widens to $42.54 Million; Net Sales Rise 37.91% to $176.24 Million

Reuters
·
Aug 06

Mirum Pharmaceuticals Q2 Adj. EPS $(1.06) Misses $(0.68) Estimate, Sales $176.200M Beat $166.122M Estimate

Benzinga Earnings
·
Aug 06

Mirum Pharmaceuticals Q2 Operating Income USD -42.537 Million

THOMSON REUTERS
·
Aug 06

Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 06

Mirum Pharmaceuticals Inc Expected to Post a Loss of 68 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Mirum Pharmaceuticals Updates Financial Calendar with Quarterly Results Call

Reuters
·
Jul 30

Mirum treatment of primary sclerosing cholangitis granted FDA orphan status

TIPRANKS
·
Jul 22

Arcutis Appoints Mirum CEO Chris Peetz to Board

Reuters
·
Jul 16

Mirum Grants Inducement Equity Awards to 6 New Hires, Including 6,300 Stock Options Priced at $122.13

Reuters
·
Jul 14

Mirum Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 14

Mirum CFO Eric Bjerkholt Disposes of Common Shares Worth $609,156.6

Reuters
·
Jul 09

FDA Priority Review For Zilurgisertib Could Be A Game Changer For Mirum Pharmaceuticals (MIRM)

Simply Wall St.
·
Jul 06

Mirum SVP, Global Controller Jolanda Howe Disposes of 2,721 Common Shares Worth $326,520

Reuters
·
Jul 03

U.S. Research Roundup- Adobe, Nike, Watts Water Technologies

Reuters
·
Jul 02